Type 1 autoimmune polyglandular disease

Annales de Medecine Interne

Volumn 150, Issue 4, 1999, Pages 313-325

  Perheentupa, Jaakko ^a,c   Miettinen, Aaro ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN;

AUTOIMMUNITY; CANDIDIASIS; DISEASE ASSOCIATION; ENDOCRINE DISEASE; IMMUNE DEFICIENCY; MULTIPLE ENDOCRINE ADENOMATOSIS; REVIEW;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOANTIGENS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; POLYENDOCRINOPATHIES, AUTOIMMUNE;

EID: 0032875354     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. AHONEN P, MYLLÄRNIEMI S, SIPILÄ I, PERHEENTUPA J: Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med, 1990, 322:1829-36.
2. PERHEENTUPA J: Autoimmune endocrinopathy-candidiasis-ectodermal dystrophy (APECED). Horm Metab Res, 1996, 28: 353-6.
3. AHONEN P, MIETTINEN A, PERHEENTUPA J: Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab, 1987, 64: 494-500.
4. LEISTI S, AHONEN P, PERHEENTUPA J: The diagnosis and staging of hypocortisolism in progressing autoimmune adrenalitis. Pediatr Res, 1983, 17: 861-7.
5. ZLOTOGORA J, SHAPIRO MS: Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet, 1992, 29: 824-6.
6. CLEMENTE MG, OBERMAYER-STRAUB P, MELONI A et al.: Cytochrome P450 1A2 is a hepatic auto-antigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab, 1997, 82: 1353-61.
7. TSATSOULIS A, SHALET M: Antisperm antibodies in the polyglandular autoimmune (PGA) syndrome type I: response to cyclical steroid therapy. Clin Endocrinol, 1991, 35: 299-303.
8. BETTERLE C, CARETTO A, ZEVIANI M et al.: Demonstration and characterization of anti-human mitochondria auto-antibodies in idiopathic hypoparathyroidism and in other conditions. Clin Exp Immunol, 1985, 62: 353-60.
9. HUNG SO, PATTERSON A: Ectodermal dysplasia associated with autoimmune disease. Br J Ophthalmol, 1984, 68: 367-9.
10. SCHERBAUM WA, WASS JAH, BESSER GM, BOTTAZZO GF, DONIACH D: Autoimmune cranial diabetes insipidus: its association with other endocrine diseases and with histiocytosis X. Clin Endorinol, 1986, 25: 411-20.
11. ARVANITAKIS C, KNOUSS RF: Selective hypopituitarism. Impaired cell-mediated immunity and chronic mucocutaneous candidiasis. J Am Med Assoc, 1973, 225: 1492-5.
12. MYLLÄRNIEMI S, PERHEENTUPA J: Oral findings in the autoimmune polyendocrinopathy-candidosis syndrome and other forms of hypoparathyroidism. Oral Surg, 1978, 45: 721-9.
13. GREENBERG MS, BRIGHTMAN VJ, LYNCH MA et al. Idiopathic hypoparathyroidism, chronic candidiasis, and dental hypoplasia. Oral Surg, 1969, 28: 42-53.
14. PERHEENTUPA J: Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED). In: ERIKSSON AW, FORSIUS HR, NEVANLINNA H, WORKMAN PL, NORIO RK (eds.): Population Structure and Genetic Disorders. Academic Press Inc. (London) Ltd. 1980, pp. 583-7.
15. LUKINMAA P-L, WALTIMO J, PIRINEN S: Microanatomy of the dental enamel in autoimmune polyendocrinopathy-candidiasisis-ectodermal dystrophy: report of three cases. J Craniofac Genet Dev Biol, 1996, 16: 174-81.
16. TARKKANEN A, MERENMIES L, PERHEENTUPA J: Ocular changes in autoimmune-polyendocrinopathy-candidosis-ectodermal dystrophy syndrome. R Soc Med Int Congr Symp Ser, 1981, 50: 677-81.
17. AALTONEN J, BJÖRSES P, SANDKUIJL L, PERHEENTUPA J, PELTONEN L: An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nature Gen, 1994, 8: 83-7.
18. AALTONEN J, HORELLI-KUITUNEN N, BIN-FAN J et al.: High resolution physical and transcriptional mapping of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) locus on chromosome 21q22.3 by FISH. Genome Res, 1997, 7: 820-9.
19. NAGAMINE K, PETERSON P, SCOTT HS et al.: Positional cloning of the APECED gene. Nature Gen, 1997, 17: 393-8.
20. THE FINNISH-GERMAN APECED CONSORTIUM: An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nature Gen, 1997, 17: 399-403.
21. BJÖRSES P, AALTONEN J, VIKMAN A et al.: Genetic homogeneity of autoimmune polyglandular disease Type I. Am J Hum Genet, 1996, 59: 879-86.
22. rd Ed. New York: Raven Press Ltd, 1993, 1353-74.
23. WIRFÄLT A: Genetic heterogeneity in autoimmune polyglandular failure. Acta Med Scand, 1981, 210: 7-13.
24. CHILGREN RA, QUIE PG, MEUWISSEN HJ, QUIE PG, HONG R: Chronic mucocutaneous candidiasis, deficiency of delayed hypersensitivity, and adrenocorticotrophic hormone deficiency. Lancet, 1967, 2: 688-93.
25. CASTELLES C, FIKRIG S, INAMDAR S et al.: Familial moniliasis, defective delayed hypersensitivity, and adrenocorticotrophic hormone deficiency. J Pediatr, 1971, 79: 72-9.
26. TOMAR RH, RAO RJ, LAWRENCE A, MOSES AM: Moniliasis and anergy in hypoparathyroidism: treatment with transfer factor. Ann Allergy, 1979, 42: 241-45.
27. ARULANANTHAM K, DWYER JM, GENEL M: Evidence for defective immunoregulation in the syndrome of familial candidiasis endocrinopathy. N Engl J Med, 1979, 300: 164-8.
28. PETERSON P, PERHEENTUPA J, KROHN KJ: Detection of candidal antigens in autoimmune polyglandular syndrome type I. Clin Diagn Lab Immunol, 1996, 3: 290-4.
29. ABBAS AK, MURPHY KM, SHER A: Functional diversity of helper T lymphocytes. Nature, 1996; 383: 787-93.
30. LIBLAU RS, SINGER SM, MCDEVITT HO: TH1 and TH2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today, 1995, 16: 34-8.
31. ANDRÉ I, GONZALEZ A, WANG B, KATZ J, BENOIST C, MATHIS D: Checkpoints in the progression of autoimmune disease: Lessons from diabetes models. Proc Natl Acad Sci USA, 1996, 93: 2260-3.
32. SEGAL BM, KLINMAN DM, SHEVACH EM: Microbial products induce autoimmune disease by an IL-12 dependent pathway. J Immunol, 1997, 155: 5087-90.
33. BLIZZARD RM, CHEE D, DAVIS W: The incidence of parathyroid and other antibodies in sera of patients with idiopathic hypoparathyroidism. Clin Exp Immunol, 1966, 1:119-28.
34. MIETTINEN A, AHONEN P, PERHEENTUPA J: Parathyroid and other auto-antibodies in patients with autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (abstract). Ped Res, 1982, 16: 889.
35. IRVINE WJ, SCARTH L: Antibody to oxyphil cells of the human parathyroid in idiopathic hypoparathyroidism. Clin Exp Immunol, 1969, 4: 505-10.
36. DONIACH D, BOTTAZZO GF: Polyendocrine auto-immunity. In: FRANKLIN EC: ed. Clinical Immunology Update. Reviews for Physicians. Edinburgh: Churchill Livingstone, 1981, 95-121.
37. POSILLICO JT, WORTSMAN J, SRIKANTA SS, EISENBARTH GS, MALLETTE LE, BROWN EM: Parathyroid cell surface auto-antibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Mineral Res, 1986, 1: 475-83.
38. POSILLICO JT, WILSON RE, SRIKANTA SS et al.: Monoclonal antibody-mediated modulation of parathyroid hormone secretion by dispersed parathyroid cells. Arch Surg, 1987, 122: 436-42.
39. BRANDI M-L, AURBACH GD, FATTOROSSI A et al.: Antibodies cytotoxic to bovine parathyroid cells in idiopathic hypoparathyroidism. Proc Natl Acad Sci USA, 1986, 83: 8366-9.
40. FATTOROSSI A, AURBACH GD, SAKAGUCHI K et al.: Anti-endothelial cell antibodies: detection and characterization in sera from patients with autoimmune hypoparathyroidism. Proc Natl Acad Sci USA, 1988, 85: 4015-9.
41. WINQVIST O, KARLSSON FA, KÄMPE O: 21-hydroxylase, a major auto-antigen in idiopathic Addison's disease. Lancet, 1992, 339: 1559-62.
42. KROHN K, UIBO R, AAVIK A, SAVILAHTI K: Identification by molecular cloning of an auto-antigen associated with Addison's disase as steroid 17α-hydroxylase. Lancet, 1992, 339: 770-3.
43. WINQVIST O, GUSTAFSSON J, RORSMAN F, KARLSSON FA, KÄMPE O: Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendcrine syndrome type I and Addison's disease. J Clin Invest, 1993, 92: 2377-85.
44. UIBO R, AAVIK E, PETERSON P, PERHEENTUPA J, KROHN KJE: Antibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in atoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab, 1994, 78: 323-8.
45. UIBO R, PERHEENTUPA J, OVOD V, KROHN KJE: Characterization of adrenal auto-antigens recognized by sera from patients with autoimmune polyglandular syndrome (APS) type I. J Autoimm, 1994, 7: 399-411.
46. SONG Y-H, CONNOR EL, MUIR A et al.: Auto-antibody epitope mapping of the 21-hydroxylase in autoimmune Addison's disease. J Clin Endocrinol Metab, 1994, 78: 1108-12.
47. WINQVIST O, GEBRE-MEDHIN G., GUSTAFSSON J et al.: Identication of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure. J Clin Endocrinol Metab, 1995, 80: 1717-23.
48. COLLS J, BETTERLE C, VOLPATO M, PRENTICE L, REES SMITH B, FURMANIAK J: Immunoprecipitation assay for auto-antibodies to steroid 21-hydroxylase in autoimmue adrenal disease. Clin Chem, 1995, 41: 375-80.
49. CHEN S, SAWICKKA J, BETTERLE C et al.: Auto-antibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab, 1996, 81: 1871-6.
50. HOEK A, SCHOEMAKER J, DREXHAGE HA: Premature ovarian failure and ovarian auto-immunity. Endocrine Rev, 1997, 18: 107-34.
51. ASAWA T, WEDLOCK N, BAUMANN-ANTCZAK A, BAUMANN-ANTCZAK A, REES SMITH B, FURMANIAK J: Naturally occurring mutations in human steroid 21-hydroxylase influence adrenal autoantibody binding. J Clin Endocrinol Metabolism, 1994, 79: 372-6.
52. FURMANIAK J, KOMINAMI S, ASAWA T, WEDLOCK N, COLLS J, REES SMITH B: Autoimmune Addison's disease - evidence for a role of steroid 21-hydroxylase auto-antibodies in adrenal insufficiency. J Clin Endocrinol Metab, 1994, 79: 1517-21.
53. AHONEN P, MIETTINEN A, PERHEENTUPA J: Cytoplasmic antibodies in patients with autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy. Acta Endocrinol, 1985, 109: (suppl 270): 78.
54. BJÖRK E, VELLOSO LA, KÄMPE O, KARLSSON FA: GAD auto-antibodies in IDDM, stiff-man syndrome and autoimmune polyendocrine syndrome type 1 recognize different epitopes. Diabetes, 1993, 43: 161-5.
55. VELLOSO LA, WINQVIST O, GUSTAFSSON J, KÄMPE O, KARLSSON FA: Auto-antibodies against a novel 51kDa islet antigen and glutamate decarboxylase isoforms in autimmune polyendocrine syndrome type I. Diabetologia, 1994, 37: 61-9.
56. TUOMI T, BJÖRSES P, FALORNI A et al.: Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab, 1996, 81: 1488-94.
57. WAGNER R, MCNALLY JM, BONIFAZIO E et al.: Lack of immunohistochemical changes in the islet of nondiabetic, autoimmune, polyendocrine patients with β-selective GAD-specific islet cell antibodies. Diabetes 1994, 43: 851-6.
58. KLEMETTI P, BJÖRSES P, TUOMI T et al.: T cell proliferation and interferon-γ response to glutamate decarboxylase in patients with autoimmune polyendocrinopathy - candidosis - ectodermal dystrophy. J Clin Immunol Allergol (in press).
59. HARRISON LC, HONEYMAN MC, DEAIZPURUA HJ et al.: Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet, 1993, 341: 1365-9.
60. 7-integrin. Diabetes, 1997, 46: 583-8.
61. HUSEBYE ES, GEBRE-MEDHIN G, TUOMI T et al.: Auto-antibodies against aromatic L-amino-acid decarboxylase in autoimmune polylendocrine syndrome Type I. J Clin Endocrinol Metab, 1997, 82: 147-150.
62. MANNS MP, GRIFFIN KJ, QUATTROCHI L et al.: Identification of cytochrome P450IA2 as a human auto-antigen. Arch Biochem Biophys, 1990, 280: 229-32.
63. SACHER M, BLÜMEL P, THALER H, MANNS M: Chronic active hepatitis with vitiligo, nail dystrophy, alopecia and a new variant of LKM antibodies. J Hepatol, 1990, 10: 364-9.
64. CLEMENTE MG, MELONI A, OBERMAYER-STRAUB P, FRAU F, MANNS MP, DE VIRGILIIS S: Cytochrome P450 2A6: a new auto-antigen in liver disease. Hepatology, 1996, 24: 233A.
65. BOURDI M, LARREY D, NATAF J et al.: Anti-liver endoplasmic reticulum auto-antibodies directed against human cytochrome P-450IA2. Specific marker off hydralazine-induced hepatitis. J Clin Invest, 1990, 85: 1967-73.
66. OBERMAYER-STRAUB P, BRAUN S, GRAMS B et al.: Different liver cytochromes P450 are auto-antigens in hepatitis patients with autoimmune hepatitis and with autoimmune polyglandular syndrome type 1. Hepatology, 1996, 24: 234A.
67. CROCK P, SALVI M, MILLER A, WALL J, GUYDA H: Detection of anti-pituitary autoantibodies by immunoblotting. J Immunol Methods, 1993, 162: 31-40.
68. DWYER DO, PERHEENTUPA J, CROCK P: Antipituitary autoantibodies associated with autoimmune polyendocrinopathy (APECED) (abstract). Horm Res, 1997, 48 (suppl 2): 187.
69. WARD L, SEIDMAN E, HUOT C et al.: Exocrine pancreatic insufficiency and autoimmune hypophysitis in a child with autoimmune polyendocrine syndrome type I (abstract). Horm Res, 1997, 48 (suppl 2): 186.
70. MIRAKIAN R, BOTTAZZO GF: The autoimmune pathogenesis of chronic gastritis and pernicious anaemia. In: BHATT HR, JAMES VHT, BESSER GM, BOTTAZZO GF, KEEN H, eds. Advances in Thomas Addison's Diseases. Bristol: Journal of Endocrinology Ltd, 1994, 193-203.
71. + -adenosine triphosphatase, the proton pump of the stomach. Gastroenterology, 1989, 96: 1434-8.
72. GOLDKORN I, GLEESON PA, TOB B-H: Gastric parietal cell antigens of 60-90, 92 and 100-120 kDa associated with autoimmune gastritis and pernicious anaemia. J Biol Chem, 1989, 264: 18769-74.
73. + ATPase vesicles isolated from the hog gastric mucosa. Biochemistry, 1990, 29: 801-6.
74. + transporting ATPase. Proc Soc Nat Acad Sci USA, 1990, 87: 6767-71.
75. + -ATPase. J Biol Chem, 1990, 265: 12123-6.
76. GOLDKORN I, GLEESON PA, TOB B-H: Reverse immunoaffmity chromatography: application to purification of the 60-90kDa gastric parietal cell auto-antigen assciated with autoimmune gastritis. Anal Biochem, 1991, 194: 433-8.
77. PADEH S, THEODOR R, JONAS A, PASSWELL JH: Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression. Arch Dis Childh, 1997, 76: 532-4.
78. BROSTOFF J, BOR S, FEIWEL M: Auto-antibodies in patients with vitiligo. Lancet, 1969, 2: 177-8.
79. HERTZ KC, GAZZE LA, KIRKPATRICK CH, KATZ SI: Autoimmune vitiligo: detection of auto-antibodies to melanin-producing ceus. N Engl J Med, 1977, 297: 246-51.
80. NAUGHTON GK, EISINGER M, BYSTRYN JC: Antibodies to normal human melanocytes in vitiligo. J Exp Med, 1983, 158: 246-51.
81. SONG Y-H, CONNER E, LI Y, ZOROVICH B, BALDUCCI P, MACLAREN N: The role of tyrosinase in autoimmune vitiligo. Lancet, 1994b, 344: 1049-52.
82. MONTAZERI A, SERRE G, KANITAKIS J: Alopecia areata. Eur J Dermatol, 1996, 6: 471-8.
83. VITALI C, DORIA A, TINCANI A et al: International survey on the management of patients with SLE. 1. General data on the participating centers and the results of a questionnaire regarding mucocutaneous involvement. Clin Exp Rheumatol, 1996, 14 (suppl 16): S17-S22.
84. TOBIN DJ, HANN SK, SONG MS, BYSTRYN JC: Hair follicle structures targeted by antibodies in patients with alopecia areata. Arch Dermatol, 1997, 133: 57-61.
85. WEETMAN AP: Antigen presentation in the pathogenesis of autoimmune endocrine disease. J Autoimm, 1995, 8: 305-12.
86. HARLEY JB, SCOFIELD RH: Systemic lupus erythematosus: RNA-protein auto-antigens, models of disease heterogeneity, and theories of etiology. J Clin Immunol, 1991, 11: 297-316.
87. MCNATTY KP, SHORT RV, BARNES EW, IRVINE WJ: The cytotoxic effect of serum from patients with Addison's disease and autoimmune ovarian failure on human granulosa cells in culture. Clin Exp Immunol, 1975, 22: 378-84.
88. BETTERLE C, ZANCHETTA R, TREVISAN A, MANTERO F, RIGON F: Complement-fixing adrenal auto-antibodies as a marker for predicting onset of idiopathic Addison's disease. Lancet, 1983, 1: 1238-41.
89. AHONEN P, KOSKIMIES S, LOKKI M-L, THLIKAINEN A, PERHEENTUPA J: Expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR. J Clin Endocrinol Metab, 1988, 66: 1152-7.
90. JANSSON R, KARLSSON A, DAHLBERG PA: Thyroxine, methimazole, and thyroid microsomal auto-antibody titres in hypothyroid Hashimoto's thyroiditis. Br Med J [Clin Res], 1985, 290: 11-2.
91. KÄMPE O, ANDERSSON A, BJÖRK E, HALLBERG A, KARLSON FA: High-glucose stimulation of 64,000-Mr islet cell auto-antigen expression. Diabetes, 1989, 38: 1326-8.
92. BUSCHARD K: The functional state of the beta cells in the pathogenesis of insulin-dependent diabetes mellitus. Auto-immunity, 1991, 10: 65-9.
93. ADORINI L, SINIGAGLIA F: Pathogenesis and immunotherapy of autoimmune diseases. Immunol Today, 1997, 18: 209-11.
94. WEINER HL: Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today, 1997, 18: 335-43.